exploring the frontiers of bioscience
The Paul G. Allen Frontiers Group takes our Founder’s enduring quest to understand the mysteries of bioscience to a global scale—beyond the science happening within the labs of the Allen Institute—by directing funding to researchers conducting cutting-edge science around the world. Our team is in continuous dialogue with scientists and visionaries in all areas of bioscience, constantly seeking the novel ideas and emerging fields where an early investment could have the power to make a difference for humankind.
The Frontiers Group encourages new ways of doing science, nurtures breakthroughs, and fosters a creative community built on a shared passion for discovery.
We seek the people and approaches at the edges of scientific exploration. We convene scientists and visionaries to identify the fields on the cusp of breakthroughs and generate ideas that will spur new directions in bioscience.
Funding new ideas
To accelerate discoveries, we encourage new approaches to address established scientific questions. We invest in investigators and centers who are gamechangers in their respective fields – innovators who are breaking down walls with the newest technologies and methodologies.
At Frontiers Group events, we bring together our community of creative thinkers and seekers, sparking conversations and collaborations that span disciplines. Our awardees become part of a network of like-minded pioneers who support and challenge each other in their efforts to tackle the biggest questions in bioscience.
News from The Paul G. Allen Frontiers Group
Random chance in early brain development sets adult fruit flies’ personalities
March 24, 2020
Brain wiring asymmetry established as animals grow influences their innate behavior, a new study finds
Competition yields new approaches to trace development, cell by cell
March 4, 2020
The Allen Institute and Sage Bionetworks announced winners of the Allen Institute Cell Lineage Reconstruction DREAM Challenge
Hodgkin lymphoma recruits and trains immune cells to help it thrive
January 14, 2020
Study also highlights possible new targets for treatment, how to better tailor cancer therapies for individual patients